Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C,...
-
Upload
gervase-potter -
Category
Documents
-
view
217 -
download
2
Transcript of Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C,...
![Page 1: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/1.jpg)
Administering Treprostinil to an Intubated PatientKristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCPDirector of Cardiopulmonary & Neurodiagnostic ServicesGood Samaritan Hospital, San José, CA
![Page 2: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/2.jpg)
Rationale
Inhaled treprostinil (Tyvaso®) is FDA approved for treatment of pulmonary hypertension
![Page 3: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/3.jpg)
Rationale
Inhaled treprostinil (Tyvaso®) is FDA approved for treatment of pulmonary hypertension
One unit dose (2.9 mL) is used each day
![Page 4: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/4.jpg)
Rationale
Inhaled treprostinil (Tyvaso®) is FDA approved for treatment of pulmonary hypertension
One unit dose (2.9 mL) is used each day
Patient takes four treatments each day
![Page 5: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/5.jpg)
Rationale
Inhaled treprostinil (Tyvaso®) is FDA approved for treatment of pulmonary hypertension
One unit dose (2.9 mL) is used each day
Patient takes four treatments each day
Proprietary ultrasonic nebulizer
![Page 6: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/6.jpg)
Rationale
![Page 7: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/7.jpg)
Methods
Four 1 mL syringes used to draw up 0.75 mL doses
![Page 8: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/8.jpg)
Methods
Four 1 mL syringes used to draw up 0.75 mL doses
Aerogen nebulizer
![Page 9: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/9.jpg)
Methods
![Page 10: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/10.jpg)
Results
Transient decrease in mean pulmonary arterial pressure (40 mm Hg 36 mm Hg)
![Page 11: Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services.](https://reader035.fdocuments.net/reader035/viewer/2022081519/56649e745503460f94b752f1/html5/thumbnails/11.jpg)
Results
Transient decrease in mean pulmonary arterial pressure (40 mm Hg 36 mm Hg)
SpO2 increase (91% 96%)